Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 237-245

  Peghini, Pietro Edmondo ^a   Fehr, Jörg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cyclin D1; Mantle cell lymphoma; Non Hodgkin lymphoma; Quantitative real time RT PCR

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; CYCLIN D1;

ARTICLE; CELL STRUCTURE; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD20; ANTIGENS, CD5; CYCLIN D1; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; PREDICTIVE VALUE OF TESTS; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0036325571     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/R2BC-2H7T-7KB6-0YG8     Document Type: Article

References (42)

1. Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome
2. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
3. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic and molecular data
4. H gene and CD5 antigen expression
5. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization
6. Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-colour interphase fluorescence in situ hybridization
7. Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization
8. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma
9. Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype
10. bcl-1, t(11;14) and mantle cell-derived lymphomas
11. Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder
12. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
13. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma
14. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma
15. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma
16. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma
17. Cyclin D1 expression in non-Hodgkin's lymphomas; detection by immunohistochemistry
18. Reliable immunostaining of cyclin D1 is difficult, but the problems can be overcome
19. Optimizing cyclin D1 immunostaining of mantle cell lymphoma
20. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas
21. Simultaneous amplification and detection of specific DNA sequences
22. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
23. Detection of specific polymerase chain reaction products by utilizing the 5′→3′ exonuclease activity of Thermus aquaticus DNA polymerase
24. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
25. Real time quantitative PCR
26. A novel method for real time quantitative RT-PCR
27. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase
28. High temperature reverse transcription and PCR with Thermus thermophilus DNA polymerase
29. European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL)
30. Lymphocyte nuclear morphology in diffuse well-differentiated lymphocytic lymphoma
31. Hyper-CVAD and high dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
32. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23
33. Mantle cell lymphoma: A clinicopathologic study of 80 cases
34. Mantle cell lymphoma: A retrospective study of 121 cases
35. Immunophenotyping of non-Hodgkin's lymphoma: Lack of correlation between immunophenotype and cell morphology
36. CD23 expression in non-Hodgkin lymphoma: Immunohistochemical demonstration using the antibody BU38 on paraffin sections
37. Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies
38. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
39. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements
40. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma
41. Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors
42. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report